Enzyme inhibitor

From WikiMD's WELLNESSPEDIA

(Redirected from Feedback inhibition)

An enzyme inhibitor is a molecule that binds to an enzyme and decreases its activity. By binding to enzymes' active sites, inhibitors reduce the compatibility of substrate and enzyme and this leads to the inhibition of Enzyme-Substrate complexes' formation, preventing the enzyme from catalyzing its reaction.

Types of Enzyme Inhibitors[edit]

Enzyme inhibitors are classified into two main types: Reversible inhibitors and Irreversible inhibitors.

Reversible Inhibitors[edit]

Reversible inhibitors bind to enzymes with non-covalent interactions such as hydrogen bonds, hydrophobic interactions, and ionic bonds. Multiple weak bonds between the inhibitor and the active site combine to produce strong and specific binding. In contrast to substrates and irreversible inhibitors, reversible inhibitors generally do not undergo chemical reactions when bound to the enzyme and can be easily removed by dilution or dialysis.

There are three kinds of reversible inhibitors: Competitive inhibitors, Noncompetitive inhibitors, and Uncompetitive inhibitors.

Competitive Inhibitors[edit]

Competitive inhibitors bind to the active site and prevent the substrate from binding there. The inhibition can be overcome by increasing the concentrations of substrate, to out-compete the inhibitor. Competitive inhibitors are often similar in structure to the real substrate.

Noncompetitive Inhibitors[edit]

Noncompetitive inhibitors bind to an enzyme at a site distinct from the active site. The enzyme-inhibitor complex can still bind substrate in the active site, forming an ESI complex, but the ESI complex does not form product.

Uncompetitive Inhibitors[edit]

Uncompetitive inhibitors bind to the enzyme-substrate complex, preventing it from releasing products. These inhibitors modify the enzyme's active site, making it less receptive to the substrate.

Irreversible Inhibitors[edit]

Irreversible inhibitors usually form covalent bonds with enzymes, irreversibly inactivating them. The inhibition cannot be reversed by an excess of substrate. Irreversible inhibitors often contain reactive functional groups such as nitrogen mustards, aldehydes, haloalkanes, alkenes, Michael acceptors, phenyl sulphonates, or fluorophosphonates.

Medical Applications[edit]

Enzyme inhibitors are used as drugs to treat diseases. They can be used to decrease abnormal enzyme activity in diseases such as cancer, HIV, and hypertension. Some of the most common enzyme inhibitors include ACE inhibitors, Protease inhibitors, and Chemotherapy drugs.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.